Drug Treatment Ipf Navigation


Drug Treatment Ipf

|

Partners
Tell A Friend about us
Drug Rehab Hamilton |
Drug Abuse Prevention |
Drug Rehab Broward County |
Alcohol Treatment 28 Days |
Alcohol Treatment Chicago |
Alcohol Treatment Vienna Va |
Port Augusta Drug Alcohol Treatment |
Drug Rehab Quakertown Pa |
Alcohol Treatment Elizabethtown Ky |
Boston Men Substance Abuse |
Drug Abuse Treatment Act 2000 |
Addiction Drug |
Dopamine Drug Treatment Brain |
Nashville Drug Alcohol Treatment |
Drug Rehab Services Bucks County Pa |

List of Drug-Alcohol-Treatment Articles

Drug Treatment Ipf Best Seller



Best Drug Treatment Ipf Products

Social bookmarking
You like it? Share it!
socialize it


Main Drug Treatment Ipf Sponsors


Drug Treatment Ipf

 

Latest Drug Treatment Ipf Link Added

Top 5 Drug and Alcohol Treatment Pages

1. Drug Rehab
2. Drug Alcohol
3. Drug Treatment
4. Drug Addiction
5. Alcohol Treatment




Submit your link on Drug Treatment Ipf!


Welcome to Drug and Alcohol Treatment


 

Drug Treatment Ipf Article

Thumbnail example

This is a selection made from among articles on Drug Treatment Ipf. For a permanent link to this article, or to bookmark it for future reading, click here.

The Picture of Drug Addiction

from:


When you think of drug addiction, what kind of picture do you get in your mind? Do you see a person dressed in tattered clothes sitting in a rain soaked alley with needle in hand? Do you picture addiction in terms of a person begging on the street for money to buy just one more hit? The picture of drug addiction can be either of these images, but you might surprised to learn that there is another side of drug addiction you may never have thought of.

Consider that the picture of drug addiction includes a man in a business suit sitting at a desk every day working a full-time job. He has a family, children, a dog, and a wife. To everyone else, he projects the picture of having it all. The only problem is, the pressure of life got to him and he looked for a way out. A colleague offered him some cocaine. He liked the way it made him feel. Now he juggles credit card advances to pay for his $100 a day habit.

The picture of drug addiction could also be the popular cheerleader at your child’s high school. She’s blonde, beautiful, smart, and personable. But every morning, she takes a shot of vodka to stop the shakes. At lunch, she drinks a six-pack in her car, and at night, she’s at all the parties drinking until someone has to bring her home because she’s passed out.

Finally, the picture of drug addiction could also be in the form of a bored housewife. She has three children, laundry, dishes, and many other responsibilities. She’s tired all the time and sometimes just can’t get out of bed because of her exhaustion. She saw something on television about housewives taking their child’s Ritalin for energy. She decides to try it with her own 7-year old’s medication. Now she has to make excuses to the pediatrician why her child has run out of medicine before he should have.

Sure, we all picture a person with drug addiction as the homeless, down-on-their luck bum (so to speak) begging on the streets for money to buy drugs, but the cold reality is that drug addiction occurs in all walks of life to all types of people. Drug addiction has no boundaries and doesn’t pick and choose its victims.

The picture of drug addiction has changed over the years to include your neighbor, your child’s teacher, and even possibly your clergy. No one is immune, but all can get help. If you notice drug addiction in someone you care about, have a talk with them and encourage them to get help for their problem. Maybe one day, the picture of drug addiction will be a blank canvas.



Drug Treatment Ipf Specific links

Drug Treatment Ipf News

Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that its iSPERSEâ„¢ inhaled drug delivery platform demonstrated the capability to formulate a wide range of drugs for inhaled administration, including antibiotics, antibodies and other macromolecules.

Read more...


Pulmatrix Announces Presentations at ATS 2012 International Conference

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that six posters on its iCALMâ„¢ and iSPERSEâ„¢ inhaled drug platforms ha

Read more...


Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced the appointment of Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer.

Read more...


First, do no harm: Danger in standard treatment for a serious lung disease

A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to the surprising results of a rigorous independent study. The findings show the importance of testing treatments that doctors give for any ...

Read more...


First, do no harm: Study finds danger in standard treatment for a serious lung disease

Results show importance of rigorous, placebo-controlled, independent evaluation of treatments for any disease

Read more...


Esbriet Drives InterMune's Revenue

InterMune posted a wider loss in the first quarter of 2012 due to higher costs.

Read more...


Late-breaking clinical trials

On Tuesday afternoon, May 22, 2012, results from seven late-breaking clinical trials will be presented in session C91 at the ATS International Conference. These studies examine treatments for ventilator-associated pneumonia, cardiac surgery associated kidney injury, septic shock, idiopathic pulmonary fibrosis, smoking cessation, malignant pleural effusion and non-cystic fibrosis bronchiectasis.

Read more...


New Study Finds Danger In Standard Treatment For Lung Disease

A new study conducted inpart by a University of Michigan lung specialists finds that a combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis.

Read more...


Press Release

Promedior Inc. Posted on:15 May 12 Promedior , Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced the appointment of Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer.

Read more...


First, Do No Harm: Study Finds Danger in a Lung Disease Treatment

A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, idiopathic pulmonary fibrosis.

Read more...